<DOC>
	<DOCNO>NCT00938392</DOCNO>
	<brief_summary>The objective study evaluate immunogenicity different formulation GSK Biologicals ' investigational vaccine GSK2186877A .</brief_summary>
	<brief_title>Study Evaluate Immunogenicity Safety Investigational Influenza Vaccine Elderly</brief_title>
	<detailed_description />
	<mesh_term>Influenza , Human</mesh_term>
	<mesh_term>Vaccines</mesh_term>
	<criteria>Subjects investigator believe comply requirement protocol enrol study . Specific attention give compliance potential subject suspect known drug alcohol abuse . A man woman 65 year age old time vaccination . Written inform consent obtain subject . Free acute aggravation health status establish clinical evaluation enter study . Any confirm suspect influenza illness within last 6 month . Previous vaccination influenza seasonal vaccine since December 2008 . Planned administration influenza vaccine study vaccine entire study period . Use investigational nonregistered product ( drug vaccine ) study vaccine ( ) within 30 day precede dose study vaccine , plan use study period . Administration license vaccine within 2 week ( inactivated vaccine ) 4 week ( live vaccine ) prior enrolment study . Planned administration vaccine foreseen study protocol Visit 2 . Administration immunoglobulins and/or blood product within 3 month precede dose study vaccine plan administration study period . Chronic administration ( defined 14 day total ) immunosuppressant immunemodifying drug within six month prior vaccine dose . For corticosteroid , mean prednisone &gt; = 0.5 mg/kg/day , equivalent . Inhaled topical steroid allow . Any confirmed suspected immunosuppressive immunodeficient condition , base medical history physical examination . History reaction hypersensitivity likely exacerbate component vaccine ( ) include egg chicken protein , include history hypersensitivity previous dose influenza vaccine . Acute chronic , clinically significant pulmonary , cardiovascular , hepatic renal functional abnormality , determine physical examination laboratory screen test . Acute disease and/or fever time enrolment . Fever define temperature &gt; = 37.5Â°C oral setting . Subjects minor illness ( mild diarrhoea , mild upper respiratory infection ) without fever may enrol discretion investigator . Any medical condition intramuscular injection contraindicate .</criteria>
	<gender>All</gender>
	<minimum_age>65 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2016</verification_date>
	<keyword>influenza infection</keyword>
	<keyword>GSK Bio 's influenza vaccine GSK2186877A</keyword>
</DOC>